{
  "timestamp": "20250104_014422",
  "model": "gpt-4o-mini",
  "interaction_type": "answer_with_CoT",
  "question_id": "71f46c1b",
  "question_text": "Patients on isoniazid which vitamin deficiency is more likely to be seen.",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert using chain-of-thought reasoning."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.\n            You are a medical expert determining the final answer.\n\n                ### Instructions:\n                - Use standard medical knowledge as the primary guide.\n                - Consider enhanced information only if it aligns with consensus.\n                - If conflicting or unclear, present the most likely correct answer based on known facts.\n                - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n            ### Question    \n            Patients on isoniazid which vitamin deficiency is more likely to be seen.\n\n            ### Options\n            opa. Vitamin B9\nopb. Vitamin B12\nopc. Vitamin B6\nopd. Vitamin B3\n\n### Reasoning Chains for Validation:\n- CHAIN: \"Isoniazid use\" -> \"inhibition of pyridoxine metabolism\" -> \"decreased vitamin B6 levels\" -> 85%\n- CHAIN: \"Isoniazid administration\" -> \"interference with vitamin B6\" -> \"risk of peripheral neuropathy\" -> 80%\n- CHAIN: \"Isoniazid treatment\" -> \"increased demand for vitamin B6\" -> \"potential deficiency\" -> 75%\n- CHAIN: \"Isoniazid\" -> \"affects vitamin B6 metabolism\" -> \"more likely to see vitamin B6 deficiency\" -> 90%\n\n### Retrieved Validation Paths:\n- (isoniazid)-TREATS->(Disease)-MANIFESTATION_OF->(uptake)-ASSOCIATED_WITH->(pyridoxine)\n- (pyridoxine)-TREATS->(Peripheral Neuropathy)\n\n            ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n                \n                ### Output Format:\n                {\n                  \"final_analysis\": \"Step-by-step reasoning, prioritizing medical consensus and acknowledging complexity if present.\",\n                  \"answer\": \"Option key (e.g. opa, opb, ...)\",\n                  \"confidence\": A number between 0-100\n                }\n            "
    }
  ],
  "response": "{\n  \"final_analysis\": \"Isoniazid is known to interfere with the metabolism of vitamin B6 (pyridoxine), leading to a deficiency. This is primarily due to isoniazid's action as a pyridoxine antagonist, which can result in peripheral neuropathy if vitamin B6 levels are not adequately maintained. While isoniazid can also affect other vitamins, the most significant and well-documented deficiency associated with its use is that of vitamin B6. Therefore, the most likely vitamin deficiency seen in patients on isoniazid is vitamin B6.\",\n  \"answer\": \"opc\",\n  \"confidence\": 90\n}",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4o-mini",
    "temperature": 0.0
  }
}